Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Moodys
Colorcon
Johnson and Johnson
McKinsey

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Claims for Patent: 9,556,445

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,556,445
Title:S-adenosylmethionine synthetase expression elements identified from Arabidopis thaliana
Abstract: The present invention provides non-coding regulatory element polynucleotide molecules isolated from the S-adenosyl methionine synthetase (SAMS3) gene of Arabidopsis thaliana and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the Arabidopsis thaliana regulatory polynucleotide sequences, and methods for preparing and using the same.
Inventor(s): Wu; Wei (St. Louis, MO), Wang; Qi (St. Louis, MO), Edgerton; Michael (St. Louis, MO), Beazley; Kim (Kirkwood, MO), Deikman; Jill (Davis, CA), Petersen; Michael W. (Sauk City, WI), Zhang; Bei (Chesterfield, MO)
Assignee: Monsanto Technology LLC (St. Louis, MO)
Application Number:14/298,785
Patent Claims:1. A regulatory polynucleotide molecule comprising the promoter sequence consisting of SEQ ID NO: 3 functional in a plant cell, wherein said promoter is operably linked to the intron sequence consisting of SEQ ID NO: 7; and wherein the regulatory polynucleotide molecule is operably linked to a heterologous transcribable polynucleotide molecule.

2. A polynucleotide construct comprising the regulatory polynucleotide molecule of claim 1.

3. The polynucleotide construct of claim 2, wherein said transcribable polynucleotide molecule is a gene of agronomic interest.

4. The polynucleotide construct of claim 2, wherein said transcribable polynucleotide molecule is a gene controlling the phenotype of a trait selected from the group consisting of: herbicide tolerance, insect control, modified yield, fungal disease resistance, virus resistance, nematode resistance, bacterial disease resistance, plant growth and development, starch production, modified oils production, high oil production, modified fatty acid content, high protein production, fruit ripening, enhanced animal and human nutrition, biopolymers, environmental stress resistance, pharmaceutical peptides and secretable peptides, improved processing traits, improved digestibility, enzyme production, flavor, nitrogen fixation, hybrid seed production, fiber production, and biofuel production.

5. The polynucleotide construct of claim 4, wherein said herbicide tolerance gene is selected from the group consisting of genes that encode for: phosphinothricin acetyltransferase, glyphosate resistant EPSPS, hydroxyphenyl pyruvate dehydrogenase, dalapon dehalogenase, bromoxynil resistant nitrilase, anthranilate synthase, glyphosate oxidoreductase and glyphosate-N-acetyl transferase.

6. A transgenic plant cell stably transformed with the polynucleotide construct of claim 2.

7. A transgenic plant stably transformed with the polynucleotide construct of claim 2.

8. A seed obtained from said transgenic plant of claim 7, wherein the seed comprises said polynucleotide construct.

9. A progeny plant grown from the seed of claim 8, wherein said progeny comprises said polynucleotide construct.

10. The transgenic plant cell of claim 6, wherein said plant cell is from a monocotyledonous plant selected from the group consisting of wheat, maize, rye, rice, corn, oat, barley, turfgrass, sorghum, millet and sugarcane.

11. The transgenic plant of claim 7, wherein said plant is a monocotyledonous plant selected from the group consisting of wheat, maize, rye, rice, corn, oat, barley, turfgrass, sorghum, millet and sugarcane.

12. A seed obtained from the transgenic plant of claim 11, wherein the seed comprises said polynucleotide construct.

13. The transgenic plant cell of claim 6, wherein said plant cell is from a dicotyledonous plant selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, sunflower and alfalfa.

14. The transgenic plant of claim 7, wherein said plant is a dicotyledonous plant selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, sunflower and alfalfa.

15. A seed obtained from the transgenic plant of claim 14, wherein the seed comprises said polynucleotide construct.

Details for Patent 9,556,445

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2018-12-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2018-12-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Monsanto Technology LLC (St. Louis, MO) 2018-12-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,556,445

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
AstraZeneca
Boehringer Ingelheim
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.